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Results: The generated pseudo-CTs for the fifteen patients 
show low mean absolute error (138 ± 17 HU) and bias (-8 ± 29 
HU) in comparison to the acquired CT. These values are in 
the same range as a suggested algorithm by Sue et. al, which 
makes use of UTE MRI acquisitions (Med Phys. 2015 
Aug;42(8):4974-86.). 
 
Conclusion: Many suggested pseudo-CT generation methods 
employ a complicated ultra-short echo time (UTE) MRI for 
better bone segmentation. 
With our new approach, we show that pseudo-CTs of 
reasonable quality can be generated without the use of UTE 
MRI acquisitions. Currently, we are still improving our 
algorithm and at a pretty early stage of the overall 
development, thus further significant improvement can be 
expected. 
Furthermore, we plan to expand our algorithm to the 
application in pediatric oncology with the aim to reduce 
necessity of CT acquisitions (ionizing radiation exposure) for 
growing patients. 
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Purpose or Objective: Proton range in patients is 
determined from the stopping power ratio (SPR) of tissues 
relative to water along the beam path. SPR map can be 
derived from dual-energy computed tomography (DECT) and 
the Bethe-Bloch equation. In this study, we propose and 
compare the accuracy and the precision of several 
procedures to estimate the SPR from DECT. 
 
Material and Methods: Image-based method of [1] and 
projection-based basis material decomposition (BMD) method 
of [2] were investigated. 2 variants for BMD were considered: 
water/compact bone basis (W/CB) and 
photoelectric/Compton basis (Ph/Co) with exponent 
optimization for the given DE spectra. BMD assumes that 
linear attenuation coefficient at any energy can be obtained 
by a linear and energy-independent combination of these 
basis functions. Electron density ρe and effective atomic 
number Zeff are common DECT outputs. For each 
decomposition method, 4 empirical relationships to convert 
DE outputs to SPR were evaluated which were all calibrated 
with materials used by [3] for the stoichiometric calibration. 
The first approach [4] was a calibrated relation between the 
logarithm of the mean excitation energy of tissues Im and 
Zeff (Zeff,ln Im). The second approach consisted in 
reconstructing the electronic cross section at 100 keV σe,100 
from the BMD results. To avoid intermediate variable Zeff, a 
novel calibrated relation between σe,100 and Im values 
(σe,100, Im) was proposed. The third method involved a 
calibration curve between (σe,100, SPR/ρe). The last 
approach consisted in the direct conversion of ρe into SPR 
through the (ρe,SPR/ρe) relation proposed by [5]. Only the 
last method can be considered independent of the energy 
spectra.  
Virtual DECT acquisitions of the ImagingRing (medPhoton, 
Salzburg) of the phantom Gammex 467 were carried out by 
means of deterministic Monte Carlo simulations in Gate with 
realistic detector response model. Scatter-free fan-beam 
acquisitions with 720 projections were considered. Realistic 
Poisson noise corresponding to a 20mGy central dose was 
added to the projections. 
 
Results: Relative errors of SPRs of phantom inserts estimated 
using 4 empirical relationships for each decomposition 
method are shown in Table1 as μ ± σ. A penalty was imposed 
to pixel values with Im, Zeff and σe values outside human 
range. Lung tissue inserts show maximum error. (σe,100, 
SPR/ρe) approach is the least appropriate in terms of 
precision. (σe,100, Im) and (Zeff,ln Im) behave in the same 
manner. Results show that the method proposed by [5] 
provides better accuracy and precision. 
 
 
 
Conclusion: Comparison of different calibration methods to 
convert DE data into SPR was carried out. A novel 
relationship between σe and Im was proposed and behaves 
similarly to (Zeff,ln Im) curve. Energy independent poly-line 
(ρe,SPR/ρe) curves present better accuracy and precision.  
DECT is a promising technique to determine the SPR of 
human tissues. Optimization of the acquisition parameters 
and the algorithm to extract the required patient information 
is mandatory. 
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Purpose or Objective: Proton and ion therapy require 
accurate prediction of particle ranges in tissue. In current 
clinical practice, computed tomography (CT) images are 
voxel-wise converted to ion-stopping power ratio maps using 
direct heuristic relations. The general validity of these 
approaches is, however, limited due to the different physical 
regimes of photon and ion interaction. Using a more 
sophisticated method based on dual-energy CT (DECT), which 
provides access to the physical quantities influencing photon 
attenuation, Hünemohr et al. (2014) reported an improved 
ion-range prediction for homogeneous tissue surrogates. 
Here, we present a major modification of the latter method, 
enabling a proper treatment of heterogeneities and mixtures 
on several structural levels, which represent a crucial feature 
of the realistic clinical situation. 
 
Material and Methods: We treat the stopping-power ratio as 
the product of the electron density relative to water and a 
correction factor that implicitly involves the logarithmic 
dependence on the mean excitation energy (I-value). The 
relative electron density, being an important parameter in 
both photon and ion energy loss, can be derived directly from 
DECT scans using a universal and robust method. The 
correction factor, however, has to be determined with an 
empirical method. For this purpose, we propose to use the 
information from CT images that is complementary to the 
relative electron density, i.e. the electronic photon 
absorption cross section relative to water. Using the 
attenuation sum rule and Bragg’s additivity rule, the relative 
cross sections and correction factors were calculated for 
single elements, tissue base materials like water, lipid, etc. 
and tabulated real tissues. 
 
Results: For a therapeutic beam energy of 200 MeV/u, the 
correction factor varies between 1.15 and 0.70 for single 
elements with atomic numbers between 1 and 100. Building 
up compounds from a certain number of elements, a 
maximum spread of possible values for the correction factor 
can be quoted for a given relative cross section, due to the 
mathematical structure of the variable space. In practice, 
this could be used as an uncertainty estimate for a given 
calibration. The accessible variable space is drastically 
reduced by admitting only tissue base materials such as 
water, lipids and hydroxylapatite. The space is further 
reduced by admitting only mixtures of real tissue materials. 
For human tissue, the correction factor is thus limited overall 
to a small range around one (0.96 - 1.02). 
 
Conclusion: With the definition of the correction factor in 
the stopping-power ratio prediction and its relation to the 
relative cross section, a mathematically rigorous treatment 
of tissue mixtures was made possible. Such mixtures 
influence CT imaging of patients e.g. in the form of volume 
averaging in a CT voxel. This thorough treatment of mixtures 
is thus essential for the clinical applicability of DECT-based 
ion-range prediction. 
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Purpose or Objective: The development of a synthetic CT 
(synCT) derived from MR images is necessary to support MR-
only treatment planning. While we have previously developed 
a synCT solution for the brain, no clear quality assurance 
workflow currently exists for synCT validation. This work uses 
a novel MR-CT compatible 3D anthropomorphic skull phantom 
(Fig 1A) to evaluate the uncertainty in an MR-only workflow 
in the brain. 
 
Material and Methods: MR images of the phantom were 
acquired on a 1.0T High-Field Open MR-Simulator (Philips 
Medical Systems, Cleveland, OH). Triple echo ultra-short 
echo time combined with mDixon (UTE/Dixon), T1-FFE, T2-
TSE, and FLAIR images MR images were acquired using an 8-
channel head coil. Bone-enhanced images were generated via 
an optimal weighted combination of inverted UTE and 
water/fat maps automatically generated from mDixon. 
Images were then semi-automatically segmented using 
Gaussian mixture modeling before generating synCTs via a 
previously described region-specific, voxel-based, weighted 
summation method. SynCTs were validated by calculating the 
mean absolute error (MAE) between SynCT and CT-SIM. DRRs 
from CT-SIM and SynCT were generated of the phantom and 
geometric fidelity was assessed via bounding box and 
landmark analysis. On-board planar (MV/KV) and volumetric 
(CBCT) images were acquired of the phantom and rigid 
registration was compared between datasets across three 
linear accelerator platforms. 
 
Results: The MAE of the synCT for the skull phantom (Fig 1E) 
was 131 HU. Embedded landmarks between the phantom CT-
SIM DRRs and SynCT DRRs for both right lateral and anterior 
projections were <1 mm (1G). However, slight image 
intensity variations were observed across the DRRs in the 
synCT as compared to the CT-SIM. Bounding box analysis of 
the skull revealed that anterior-posterior DRRs were <1 mm 
different between synCT and CT-SIM while lateral DRRs had a 
slightly higher uncertainty in the anterior-posterior dimension 
(~2 mm). MV and KV planar image registrations were within 
0.7 mm for all linear accelerators. CBCT/CT-SIM and 
CBCT/SynCT rigid registrations were <0.4 mm different. 
 
 
 
Conclusion: DRRs yielded comparable geometry between CT 
and synCT. Future work will involve an intensity 
normalization for synCT DRRs. Image registrations were 
within clinically acceptable ranges. Efforts are needed to 
combine geometric and dosimetric errors of the entire synCT 
pipeline; establishing QA workflows to quantify these 
uncertainties are necessary for MR-only treatment planning. 
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Purpose or Objective: Due to the spatial heterogeneity of 
tumors, the change of tumor size and the whole-tumor 
average method used in routine care do not reliably identify 
patients’ histologic response to therapy in sarcomas, thus 
compromising tumor control in the context of precision 
medicine. In this study, we investigated the utility of 
dynamic contrast-enhanced MRI (DCE-MRI) combined with the 
voxel-wise image analysis approach as an early predictive 
biomarker for efficacy of neoadjuvant chemoradiation 
therapy in sarcoma. 
 
Material and Methods: Serial DCE-MRI scans were performed 
on days before therapy (time point 1, TP1) and after 2 weeks 
of chemoradiation therapy (time point 2, TP2) in twelve 
